share_log

B of A Securities Downgrades Perspective Therapeutics to Neutral, Lowers Price Target to $6

Benzinga ·  Nov 25 21:05  · Ratings

B of A Securities analyst Alec Stranahan downgrades Perspective Therapeutics (AMEX:CATX) from Buy to Neutral and lowers the price target from $24 to $6.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment